229 In another randomized, double-blind, placebo-controlled trial of 300 people with high cholesterol levels and at high risk of cardiovascular disease, subjects were randomized to receive either 180 mg of bempedoic acid, 10 mg of ezetimibe (which prevents the intestinal absorption of cholesterol), a combination of the two medications (180 mg of bempedoic acid and 10 mg of ezetimibe), or placebo in addition to stable statin therapy for 12 weeks
With a favorable safety profile based on the research to date, BPC-157 is actively studied in contexts of wound healing, injury recovery, neuroprotection, and muscle repair
,
Suitable for custom formulations at small or large scale
BPC157 Pentadecapeptide, TB500 Thymosin-B4, Amino Acid L-Lysine Do not exceed recommended dose, consult your doctor about research
Toxicity evaluation According to a patent, "Short duration safety studies with Dihexa have uncovered no apparent toxicity